503.90
United Therapeutics Corp (UTHR) 最新ニュース
United Therapeutics Corp. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics - Markets Mojo
United Therapeutics Corp. Hits New 52-Week High at $537.11 - Markets Mojo
H.C. Wainwright raises United Therapeutics stock price target to $600 - Investing.com Nigeria
United Therapeutics Hits Day High with 13% Surge in Strong Intraday Performance - Markets Mojo
United Therapeutics (NASDAQ:UTHR) Given New $600.00 Price Target at HC Wainwright - MarketBeat
These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings - Benzinga
Why United Therapeutics (UTHR) Shares Are Sliding Today - Finviz
Oppenheimer Raises United Therapeutics (UTHR) Price Target to $6 - GuruFocus
Wells Fargo Raises Price Target for United Therapeutics (UTHR) t - GuruFocus
MannKind’s Stock Plummets as United Therapeutics Unveils Rival Product - StocksToTrade
Wells Fargo & Company Issues Positive Forecast for United Therapeutics (NASDAQ:UTHR) Stock Price - MarketBeat
United Therapeutics Corporation (NASDAQ:UTHR) Q4 2025 Earnings Call Transcript - Insider Monkey
MANNKIND CORP SEC 10-K Report - TradingView
United Therapeutics Q4 Earnings Call Highlights - Yahoo Finance
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus
TD Cowen raises United Therapeutics stock price target on growth outlook - Investing.com Nigeria
BofA raises United Therapeutics stock price target on earnings beat By Investing.com - Investing.com Canada
MannKind stock plummets after partner United Therapeutics unveils new 'category killer product' - MSN
United Therapeutics (NASDAQ:UTHR) Director Christopher Causey Sells 1,000 Shares - MarketBeat
United Therapeutics Corp (UTHR) Q4 2025 Earnings Call Highlights: Record Revenue and Promising Innovations - GuruFocus
United Therapeutics Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
BofA raises United Therapeutics stock price target on earnings beat - Investing.com
United Therapeutics (UTHR) Plans New Inhaler, Impacting MannKind (MNKD) and Liquidia (LQDA) - GuruFocus
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Asianet Newsable
Earnings call transcript: United Therapeutics beats Q4 2025 EPS estimates By Investing.com - Investing.com Canada
MannKind stock tumbles 37% on United Therapeutics inhaler news - Investing.com
United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates - Nasdaq
United Therapeutics (UTHR) Stock: Surges on Record $3.18B Revenue and Breakout Tyvaso Growth - CoinCentral
United Therapeutics Q4 2025 slides: EPS beat drives stock surge - Investing.com
MannKind (MNKD) Shares Plummet Amid United Therapeutics Announcement - GuruFocus
United Therapeutics Stock Rises 9% Over Increased Earnings In Q4 - Nasdaq
United Therapeutics stock hits all-time high at $520.00 - Investing.com
United Therapeutics Q4 2025 slides: EPS beat drives stock surge By Investing.com - Investing.com UK
Earnings call transcript: United Therapeutics beats Q4 2025 EPS estimates - Investing.com
United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates - Finviz
UTHR Stock Price and Chart — NASDAQ:UTHR - TradingView
United Therapeutics Corp. (NASDAQ:UTHR) Reports Record Annual Revenue Despite Q4 Top-Line Miss - ChartMill
United Therapeutics Q4 Earnings Beat Expectations - Intellectia AI
United Therapeutics (UTHR) Surpasses EPS Expectations in Q4 - GuruFocus
United Therapeutics (UTHR) Reports Record Revenue but Misses Q4 Forecasts - GuruFocus
United Therapeutics: Fourth Quarter Earnings Overview - Bitget
United Therapeutics: Q4 Earnings Snapshot - marketscreener.com
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
United Therapeutics stock falls nearly 5% on revenue miss despite earnings beat - Investing.com
UNITED THERAPEUTICS Corp SEC 10-K Report - TradingView
United Therapeutics Corp Q4 Profit Rises - Nasdaq
Michael Benkowitz Sells 14,440 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan
United Therapeutics earnings up next: Tyvaso seasonality in focus - Investing.com
United Therapeutics Set to Announce Q4 Earnings on February 25 - Intellectia AI
Insights Ahead: United Therapeutics's Quarterly Earnings - Benzinga
United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For - Finviz
United Therapeutics Corporation (UTHR) Stock Analysis: Potential Upside of 13.77% Amid Robust Pipeline and Strategic Collaborations - DirectorsTalk Interviews
United Therapeutics leadership to give March 2 update at TD Cowen - Stock Titan
Vanguard Group Inc. Lowers Position in United Therapeutics Corporation $UTHR - MarketBeat
Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance
Insider Selling: United Therapeutics (NASDAQ:UTHR) EVP Sells 8,300 Shares of Stock - MarketBeat
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight (2026-02-19) - Seeking Alpha
AnaptysBio (ANAB) to Release Quarterly Earnings on Thursday - Defense World
Cabot Corporation (NYSE:CBT) Given Average Rating of “Hold” by Analysts - Defense World
Vertex Casgevy Rollout Tests Gene Editing Role In Vertex Earnings Story - simplywall.st
Oppenheimer & Co. Inc. Takes $407,000 Position in BridgeBio Pharma, Inc. $BBIO - Defense World
Shell Asset Management Co. Decreases Position in United Therapeutics Corporation $UTHR - Defense World
大文字化:
|
ボリューム (24 時間):